Promoting Engagement and COVID-19 Testing for Health

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT06141850
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • COVID-19 Test Reporting — BEHAVIORAL
    Participants will use a simple text-based data reporting tool which they will be asked to use to report any COVID-19 testing during the 12-month long study.
  • Personalized Nudges via Text Messaging — BEHAVIORAL
    Weekly behavioral nudges via mobile phone text messages, personalized to participants' diabetes status, race/ethnicity, age group, sex, and/or vaccine/testing history, will be sent in weeks 1-16 of the intervention to encourage adherence to COVID-19 testing and preventive behaviors as well as other behaviors important for diabetes management, prevention, or care.
  • Non-personalized Nudges via Text Messaging — BEHAVIORAL
    Weekly behavioral nudges via mobile phone text messages will be sent in weeks 1-16 of the intervention sharing tips lifestyle behaviors important for diabetes management and prevention (e.g., exercise, eating a healthy diet, etc.).

Study Details

PEACH2 is a community-based study, targeting individuals affected by diabetes. Study participants will be randomized into the PEACH2 Intervention Arm or the Control Arm. The intervention lasts for 16 weeks and participants will be followed for 12 months in total.

Key Dates

Start date
Dec 6, 2023
Status verified
Feb 2026
Primary completion
Jan 8, 2025
Completion
Mar 25, 2025

Study Design

Enrollment
290 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Project PEACH2 Intervention
    In addition to a text-based reporting tool for reporting COVID-19 testing, participants randomized to the Project PEACH2 intervention will be sent weekly behavioral nudges via mobile phone text message to encourage adherence to COVID-19 testing and preventive behaviors.
  • Active Comparator: Control Group
    Participants randomized to the control group will receive access to the text-based COVID-19 reporting tool and receive weekly texts on diabetes prevention, management or care.

Primary Outcome Measure

Number of Participants With Symptoms Who Use a COVID-19 Test [ Time Frame: Baseline, Weeks 4, 8, and 12 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Emory UniversityAtlantaGeorgia30322-

Find similar trials in Atlanta, GA

By condition
COVID-19 / long COVID
By specialty
Infectious disease
By research site
Emory University· Atlanta, GA

Related Studies